Gene analysis (methyl cpg binding protein 2) full sequence analysis
Medicare pricing data for 39 providers across 7 states
Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.
💡 What You Should Know
Gene analysis (methyl cpg binding protein 2) full sequence analysis (HCPCS code 81302) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $517.16, but hospitals typically charge $552.86 — a 1.1x markup. Prices vary significantly by state and provider.
🏷️ Typical Out-of-Pocket Cost
Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $517.16, your out-of-pocket cost would be approximately $103.43. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.
What Hospitals Charge vs. What Medicare Pays
Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $517.16 on average.
Cost by State
Medicare-allowed amounts vary significantly by state
| State | Allowed Cost | Hospital Charge | Providers | Services | vs. National |
|---|---|---|---|---|---|
| Louisiana | $517 | $539 | 2 | 96 | +0.0% |
| New Jersey | $517 | $531 | 3 | 1,874 | +0.0% |
| Oklahoma | $517 | $734 | 3 | 440 | +0.0% |
| Pennsylvania | $517 | $529 | 1 | 1,107 | +0.0% |
| Texas | $517 | $539 | 14 | 8,371 | +0.0% |
| Arizona | $517 | $700 | 1 | 128 | +0.0% |
| Florida | $516 | $595 | 13 | 1,856 | -0.2% |
⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.
💊 Need post-procedure medications? Check costs on OpenPrescriber